Certified by Founder Lodge
EcoR1 Capital, LLC
United States - San Francisco Bay Area
INVESTOR
1 Disclosed Funding Rounds $50,000,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
EcoR1 Capital, LLC is a biotech focused investment advisory firm.
| Company | Date | Round | Raised |
|---|---|---|---|
 ReCode Therapeutics |
September, 20 ,2023 | Series B | $50,000,000 |
 Attovia Therapeutics |
May, 14 ,2024 | Series B | $105,000,000 |
 Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
 Diagonal Therapeutics |
January, 13 ,2026 | Series B | $125,000,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
Acurion, Inc. | $4,300,000 | (Apr 3, 2026)
EnerVenue | $300,000,000 | (Apr 3, 2026)
Monarch Quantum | $55,000,000 | (Apr 3, 2026)
Numos | $4,250,000 | (Apr 3, 2026)
Gander Robotics | $1,100,000 | (Apr 3, 2026)
